Listing practices for morbidly obese patients at liver transplantation centers in the United States

Experimental and Clinical Transplantation

Volumn 14, Issue 6, 2016, Pages 646-649

  Halegoua De Marzio, Dina L ^a   Wong, She Yan ^a   Fenke, Jonathan M ^a   Doria, Cataldo ^a   Sass, David A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Body mass index; Morbid obesity; Operative risk

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL PRACTICE; CONTROLLED STUDY; E-MAIL; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; ONLINE SYSTEM; POSTOPERATIVE COMPLICATION; REFERENCE VALUE; SURGICAL RISK; TREATMENT RESPONSE; UNITED STATES; WOUND HEALING IMPAIRMENT; COMPLICATION; LENGTH OF STAY; LIVER DISEASES; MORTALITY; SURVIVAL RATE;

BODY MASS INDEX; FEMALE; HUMANS; LENGTH OF STAY; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; OBESITY, MORBID; SURVIVAL RATE; UNITED STATES;

EID: 85006263459     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2015.0247     Document Type: Article

References (14)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555. doi: 10.1001/jama.295.13.1549.
2. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med. 2003;163(18):2146-2148. doi: 10.1001/archinte.163.18.2146.
3. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004;2(12):1048-1058.
4. Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl. 2006;12(4):523-534. doi: 10.1002/lt.20738
5. Zezos P, Renner EL. Liver transplantation and non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20(42):15532-15538. doi: 10.3748/wjg.v20.i42.15532.
6. Choban PS, Flancbaum L. The impact of obesity on surgical outcomes: a review. J Am Coll Surg. 1997;185(6):593-603
7. Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg. 2009;250(1):166-172. doi: 10.1097/SLA.0b013e3181ad8935.
8. Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant. 2008;8(3):667-672. doi: 10.1111/j.1600-6143.2007.02100.x
9. Watt KDS. Obesity and metabolic complications of liver transplantation. Liver Transpl. 2010;16(suppl 2):S65-S71. doi: 10.1002/lt.22155.
10. Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547-555. doi: 10.1053/j.gastro.2014.11.039.
11. Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology. 2014;59(6):2188-2195. doi: 10.1002/hep.26986.
12. Segev DL, Thompson RE, Locke JE, et al. Prolonged waiting times for liver transplantation in obese patients. Ann Surg. 2008;248(5): 863-870. doi: 10.1097/SLA.0b013e31818a01ef.
13. Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35(1):105-109. doi: 10.1053/jhep.2002.30318.
14. Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013;13(2):363-368. doi: 10.1111/j.1600-6143.2012.04318.x